EMEA-000637-PIP02-10-M06
Key facts
| Invented name |
Fosrenol and associated names
|
| Active substance |
Lanthanum carbonate hydrate
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0303/2018
|
| PIP number |
EMEA-000637-PIP02-10-M06
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of hyperphosphataemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Takeda Pharmaceuticals International AG Ireland Branch
E-mail: medinfoemea@takeda.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|